Surgery Beats Conservative Care for Heart Health in Adrenal Tumor Patients
International study shows surgical treatment significantly reduces cardiovascular risks compared to medication alone.
157 articles in this topic
International study shows surgical treatment significantly reduces cardiovascular risks compared to medication alone.
New research reveals why Addison's disease patients face higher mortality despite treatment and explores promising therapeutic approaches.
Inclisiran safely reduced LDL cholesterol by 28% in adolescents with familial hypercholesterolemia, offering hope for early intervention.
New research examines whether the cholesterol-lowering drug inclisiran could benefit pediatric patients with genetic high cholesterol.
35-year study reveals people with high genetic diabetes risk face dramatically increasing disease rates in modern environments.
Comprehensive review reveals estrogen-only therapy carries lower breast cancer risk than combined hormone treatments during menopause.
Three-month romosozumab protocol offers pragmatic solution for osteoporosis treatment with potentially improved patient outcomes.
Three months of romosozumab plus denosumab matched 12 months of romosozumab alone for bone strength gains in postmenopausal women.
New research reveals how diabetes and obesity trigger bone inflammation and disrupt key signaling pathways, increasing fracture risk in older women.
New research reveals which bariatric surgery works best and identifies patient factors that predict long-term success.
New research reveals cardiovascular-kidney-metabolic syndrome stages predict cancer risk through inflammatory pathways.
Advanced incretin-based therapies show potential for major weight loss while protecting heart, kidney, liver, and brain health.